Literature DB >> 25732147

Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.

J M Coughlin, T Tanaka, A Marsman, H Wang, S Bonekamp, P K Kim, C Higgs, M Varvaris, R A E Edden, M Pomper, D Schretlen, P B Barker, A Sawa1.   

Abstract

Aberrant function of glutamatergic pathways is likely to underlie the pathology of schizophrenia. Evidence of oxidative stress in the disease pathology has also been reported. N-Acetylaspartate (NAA) is metabolically linked to both cascades and may be a key marker in exploring the interconnection of glutamatergic pathways and oxidative stress. Several studies have reported positive correlation between the levels of NAA and Glx (the sum of glutamate and glutamine) in several brain regions in healthy subjects, by using proton magnetic resonance spectroscopy ([(1)H]MRS). Interestingly, one research group recently reported decoupling of the relationship between NAA and Glx in the hippocampus of patients with schizophrenia. Here we report levels of NAA and Glx measured using [(1)H]MRS, relative to the level of creatine (Cr) as an internal control. The dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) in 25 patients with schizophrenia and 17 matched healthy controls were studied. In DLPFC, NAA/Cr and Glx/Cr were significantly positively correlated in healthy controls after correction for the effect of age and smoking status and after correction for multiple comparisons (r= 0.627, P= 0.017). However, in patients with schizophrenia, the positive correlation between NAA/Cr and Glx/Cr was not observed even after correcting for these two variables (r= -0.330, P= 0.124). Positive correlation between NAA/Cr and Glx/Cr was not observed in the ACC in both groups. Decoupling of NAA and Glx in the DLPFC may reflect the interconnection of glutamatergic pathways and oxidative stress in the pathology of schizophrenia, and may possibly be a biomarker of the disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25732147      PMCID: PMC4509630          DOI: 10.2174/1566524015666150303104811

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  40 in total

1.  Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia.

Authors:  A D Gigante; A C Andreazza; B Lafer; L N Yatham; C L Beasley; L T Young
Journal:  Neurosci Lett       Date:  2011-10-04       Impact factor: 3.046

2.  Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia.

Authors:  Nina V Kraguljac; Meredith A Reid; David M White; Jan den Hollander; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

3.  Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

Authors:  Lawrence S Kegeles; Xiangling Mao; Arielle D Stanford; Ragy Girgis; Najate Ojeil; Xiaoyan Xu; Roberto Gil; Mark Slifstein; Anissa Abi-Dargham; Sarah H Lisanby; Dikoma C Shungu
Journal:  Arch Gen Psychiatry       Date:  2012-01-02

4.  Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia.

Authors:  J M Coughlin; K Ishizuka; S I Kano; J A Edwards; F T Seifuddin; M A Shimano; E L Daley; P P Zandi; F M Leweke; N G Cascella; M G Pomper; R H Yolken; A Sawa
Journal:  Mol Psychiatry       Date:  2012-02-21       Impact factor: 15.992

Review 5.  Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

Authors:  Anouk Marsman; Martijn P van den Heuvel; Dennis W J Klomp; René S Kahn; Peter R Luijten; Hilleke E Hulshoff Pol
Journal:  Schizophr Bull       Date:  2011-07-11       Impact factor: 9.306

6.  Glutathione is a physiologic reservoir of neuronal glutamate.

Authors:  Minori Koga; Anthony V Serritella; Marcus M Messmer; Akiko Hayashi-Takagi; Lynda D Hester; Solomon H Snyder; Akira Sawa; Thomas W Sedlak
Journal:  Biochem Biophys Res Commun       Date:  2011-04-24       Impact factor: 3.575

7.  Anterior cingulate and cerebellar GABA and Glu correlations measured by ¹H J-difference spectroscopy.

Authors:  Kevin W Waddell; Parham Zanjanipour; Subechhya Pradhan; Lei Xu; Edward B Welch; James M Joers; Peter R Martin; Malcolm J Avison; John C Gore
Journal:  Magn Reson Imaging       Date:  2010-09-29       Impact factor: 2.546

8.  Hierarchical structure of the cognitive processes in schizophrenia: the fundamental role of processing speed.

Authors:  N Ojeda; J Peña; D J Schretlen; P Sánchez; E Aretouli; E Elizagárate; J Ezcurra; M Gutiérrez
Journal:  Schizophr Res       Date:  2012-01-05       Impact factor: 4.939

Review 9.  Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia.

Authors:  Peter J Uhlhaas
Journal:  Curr Opin Neurobiol       Date:  2012-12-07       Impact factor: 6.627

10.  GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

Authors:  M J Gandal; J Sisti; K Klook; P I Ortinski; V Leitman; Y Liang; T Thieu; R Anderson; R C Pierce; G Jonak; R E Gur; G Carlson; S J Siegel
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

View more
  11 in total

1.  Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.

Authors:  Allison S Brandt; Paul G Unschuld; Subechhya Pradhan; Issel Anne L Lim; Gregory Churchill; Ashley D Harris; Jun Hua; Peter B Barker; Christopher A Ross; Peter C M van Zijl; Richard A E Edden; Russell L Margolis
Journal:  Schizophr Res       Date:  2016-02-28       Impact factor: 4.939

2.  A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia.

Authors:  Nina V Kraguljac; Charity J Morgan; Meredith A Reid; David M White; Ripu D Jindal; Soumya Sivaraman; Bridgette K Martinak; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2019-01-07       Impact factor: 4.939

Review 3.  Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.

Authors:  Tomomi Nakahara; Sakiko Tsugawa; Yoshihiro Noda; Fumihiko Ueno; Shiori Honda; Megumi Kinjo; Hikari Segawa; Nobuaki Hondo; Yukino Mori; Honoka Watanabe; Kazuho Nakahara; Kazunari Yoshida; Masataka Wada; Ryosuke Tarumi; Yusuke Iwata; Eric Plitman; Sho Moriguchi; Camilo de la Fuente-Sandoval; Hiroyuki Uchida; Masaru Mimura; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2021-09-28       Impact factor: 15.992

4.  N-Acetyl-Aspartate in the dorsolateral prefrontal cortex in men with schizophrenia and auditory verbal hallucinations: A 1.5 T Magnetic Resonance Spectroscopy Study.

Authors:  Marion Psomiades; Marine Mondino; Clara Fonteneau; Remy Bation; Frederic Haesebaert; Marie-Françoise Suaud-Chagny; Jerome Brunelin
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

5.  Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation.

Authors:  Charles P Lewis; John D Port; Caren J Blacker; A Irem Sonmez; Bhedita J Seewoo; Jarrod M Leffler; Mark A Frye; Paul E Croarkin
Journal:  Transl Psychiatry       Date:  2020-04-23       Impact factor: 6.222

Review 6.  Frontal neural metabolite changes in schizophrenia and their association with cognitive control: A systematic review.

Authors:  Bradley J Dixon; Jyothika Kumar; Claudia Danielmeier
Journal:  Neurosci Biobehav Rev       Date:  2021-12-02       Impact factor: 8.989

7.  Anterior cingulate cortex-related connectivity in first-episode schizophrenia: a spectral dynamic causal modeling study with functional magnetic resonance imaging.

Authors:  Long-Biao Cui; Jian Liu; Liu-Xian Wang; Chen Li; Yi-Bin Xi; Fan Guo; Hua-Ning Wang; Lin-Chuan Zhang; Wen-Ming Liu; Hong He; Ping Tian; Hong Yin; Hongbing Lu
Journal:  Front Hum Neurosci       Date:  2015-11-03       Impact factor: 3.169

Review 8.  Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.

Authors:  João M N Duarte; Lijing Xin
Journal:  Neurochem Res       Date:  2018-04-03       Impact factor: 3.996

9.  Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients.

Authors:  Badari Birur; Nina Vanessa Kraguljac; Lawrence VerHoef; Charity J Morgan; Ripu Daman Jindal; Meredith Amanda Reid; Austin Luker; Adrienne Carol Lahti
Journal:  Transl Psychiatry       Date:  2020-01-21       Impact factor: 6.222

10.  The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.

Authors:  Amira Bryll; Wirginia Krzyściak; Paulina Karcz; Natalia Śmierciak; Tamas Kozicz; Justyna Skrzypek; Marta Szwajca; Maciej Pilecki; Tadeusz J Popiela
Journal:  Biomolecules       Date:  2020-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.